Labeler
Zydus Pharmaceuticals USA Inc. NDC Codes
Zydus Pharmaceuticals USA Inc. lists 629 finished drug products in the FDA NDC Directory under NDC labeler codes 68382, 70710.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Isotretinoin, Riociguat, brivaracetam, tofacitinib, Eltrombopag, Beizray, Carbidopa and Levodopa, Jaythari, Deflazacort, Ascorbic acid, gadobutrol, Verapamil hydrochloride, Diazepam, gabapentin, oxcarbazepine
- Active ingredients
- Deflazacort, Isotretinoin, Riociguat, Brivaracetam, Tofacitinib citrate, Eltrombopag olamine, Carbidopa, Levodopa, Ascorbic acid, Gadobutrol, Verapamil hydrochloride, Diazepam
- NDC labeler codes
- 68382, 70710
- Strengths (from the 100 most recently listed products)
- Ascorbic acid 500 mg/mL; Gadobutrol 604.72 mg/mL; Docetaxel anhydrous 20 mg/mL; Deflazacort 22.75 mg/mL; Deflazacort 6 mg/1; Deflazacort 18 mg/1; Deflazacort 30 mg/1; Deflazacort 36 mg/1; Riociguat .5 mg/1; Riociguat 1 mg/1; Riociguat 1.5 mg/1; Riociguat 2 mg/1; Riociguat 2.5 mg/1; Fluvoxamine maleate 100 mg/1; Fluvoxamine maleate 150 mg/1; Sugammadex sodium 200 mg/2mL; Sugammadex sodium 500 mg/5mL; Ranibizumab .3 mg/.05mL; Ranibizumab .5 mg/.05mL; Tofacitinib citrate 10 mg/1
- Dosage forms
- Tablet, Tablet, Film coated, Injection, Injection, Solution, Capsule, Capsule, Extended release, Kit, Gel, Tablet, Extended release, Tablet, Film coated, Extended release, Suspension, Liquid, Tablet, For suspension, Powder, For solution
- Routes
- Oral, Intravenous, Intramuscular, Subcutaneous, Rectal, Intravitreal
- Drug classes (FDA established)
- Corticosteroid, Serotonin Reuptake Inhibitor, Retinoid, Soluble Guanylate Cyclase Stimulator, Janus Kinase Inhibitor, Thrombopoietin Receptor Agonist, Aromatic Amino Acid, Anti-epileptic Agent, Vitamin C, Gadolinium-based Contrast Agent, Calcium Channel Blocker, Benzodiazepine, Angiotensin 2 Receptor Blocker, Neprilysin Inhibitor, Tetracycline-class Drug, Vascular Endothelial Growth Factor Inhibitor, Diagnostic Dye, Nitrogen Binding Agent, Sodium-Glucose Cotransporter 2 Inhibitor, Endothelin Receptor Antagonist, Microtubule Inhibitor, CCR5 Co-receptor Antagonist, Kinase Inhibitor, Calcitonin, Oxidation-Reduction Agent, Phosphate Binder, Xanthine Oxidase Inhibitor, Arteriolar Vasodilator, Enzyme Stabilizer, Glucosylceramide Synthase Inhibitor
- HCPCS / J-code
- J2778 — Injection, ranibizumab, 0.1 mg
- Package NDCs
- 169 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Amitriptyline Hydrochloride | Amitriptyline hydrochloride 10 mg/1 | Tablet, Film coatedOral | 70710-1225 | 70710-1225-0070710-1225-01 | — |
| Amitriptyline Hydrochloride | Amitriptyline hydrochloride 25 mg/1 | Tablet, Film coatedOral | 70710-1226 | 70710-1226-0070710-1226-01 | — |
| Amitriptyline Hydrochloride | Amitriptyline hydrochloride 50 mg/1 | Tablet, Film coatedOral | 70710-1227 | 70710-1227-0070710-1227-01 | — |
| Amitriptyline Hydrochloride | Amitriptyline hydrochloride 75 mg/1 | Tablet, Film coatedOral | 70710-1228 | 70710-1228-0070710-1228-01 | — |
| Amitriptyline Hydrochloride | Amitriptyline hydrochloride 100 mg/1 | Tablet, Film coatedOral | 70710-1229 | 70710-1229-0070710-1229-01 | — |
| Amitriptyline Hydrochloride | Amitriptyline hydrochloride 150 mg/1 | Tablet, Film coatedOral | 70710-1230 | 70710-1230-0070710-1230-01 | — |
| Trazodone Hydrochloride | Trazodone hydrochloride 50 mg/1 | TabletOral | 68382-805 | 68382-0805-0168382-0805-0568382-0805-06+3 more | — |
| Trazodone Hydrochloride | Trazodone hydrochloride 100 mg/1 | TabletOral | 68382-806 | 68382-0806-0168382-0806-0568382-0806-06+3 more | — |
| Trazodone Hydrochloride | Trazodone hydrochloride 150 mg/1 | TabletOral | 68382-807 | 68382-0807-0168382-0807-0568382-0807-06+3 more | — |
| Trazodone Hydrochloride | Trazodone hydrochloride 300 mg/1 | TabletOral | 68382-808 | 68382-0808-0168382-0808-0568382-0808-06+3 more | — |
| fesoterodine fumarate | Fesoterodine fumarate 4 mg/1 | Tablet, Film coated, Extended releaseOral | 68382-479 | 68382-0479-0668382-0479-1668382-0479-77 | — |
| fesoterodine fumarate | Fesoterodine fumarate 8 mg/1 | Tablet, Film coated, Extended releaseOral | 68382-480 | 68382-0480-0668382-0480-1668382-0480-77 | — |
| Labetalol Hydrochloride | Labetalol hydrochloride 100 mg/1 | Tablet, Film coatedOral | 68382-798 | 68382-0798-0168382-0798-0568382-0798-06+1 more | — |
| Labetalol Hydrochloride | Labetalol hydrochloride 200 mg/1 | Tablet, Film coatedOral | 68382-799 | 68382-0799-0168382-0799-0568382-0799-06+1 more | — |
| Labetalol Hydrochloride | Labetalol hydrochloride 300 mg/1 | Tablet, Film coatedOral | 68382-800 | 68382-0800-0168382-0800-0568382-0800-06+1 more | — |
| Azathioprine | Azathioprine 25 mg/1 | TabletOral | 68382-118 | 68382-0118-0168382-0118-05 | — |
| Azathioprine | Azathioprine 75 mg/1 | TabletOral | 68382-119 | 68382-0119-0168382-0119-05 | — |
| Azathioprine | Azathioprine 100 mg/1 | TabletOral | 68382-120 | 68382-0120-0168382-0120-05 | — |
| Tiadylt ERdiltiazem hydrochloride | Diltiazem hydrochloride 120 mg/1 | Capsule, Extended releaseOral | 68382-745 | 68382-0745-0168382-0745-0568382-0745-06+2 more | — |
| Tiadylt ERdiltiazem hydrochloride | Diltiazem hydrochloride 180 mg/1 | Capsule, Extended releaseOral | 68382-746 | 68382-0746-0168382-0746-0568382-0746-06+2 more | — |
| Tiadylt ERdiltiazem hydrochloride | Diltiazem hydrochloride 240 mg/1 | Capsule, Extended releaseOral | 68382-747 | 68382-0747-0168382-0747-0568382-0747-06+2 more | — |
| Tiadylt ERdiltiazem hydrochloride | Diltiazem hydrochloride 300 mg/1 | Capsule, Extended releaseOral | 68382-748 | 68382-0748-0168382-0748-0568382-0748-06+2 more | — |
| Tiadylt ERdiltiazem hydrochloride | Diltiazem hydrochloride 360 mg/1 | Capsule, Extended releaseOral | 68382-749 | 68382-0749-0168382-0749-0568382-0749-06+2 more | — |
| Tiadylt ERdiltiazem hydrochloride | Diltiazem hydrochloride 420 mg/1 | Capsule, Extended releaseOral | 68382-750 | 68382-0750-0168382-0750-0568382-0750-06+2 more | — |
| diltiazem hydrochloride | Diltiazem hydrochloride 120 mg/1 | Capsule, Extended releaseOral | 68382-595 | 68382-0595-0168382-0595-0568382-0595-06+2 more | — |
| diltiazem hydrochloride | Diltiazem hydrochloride 180 mg/1 | Capsule, Extended releaseOral | 68382-596 | 68382-0596-0168382-0596-0568382-0596-06+2 more | — |
| diltiazem hydrochloride | Diltiazem hydrochloride 240 mg/1 | Capsule, Extended releaseOral | 68382-597 | 68382-0597-0168382-0597-0568382-0597-06+2 more | — |
| diltiazem hydrochloride | Diltiazem hydrochloride 300 mg/1 | Capsule, Extended releaseOral | 68382-598 | 68382-0598-0168382-0598-0568382-0598-06+2 more | — |
| diltiazem hydrochloride | Diltiazem hydrochloride 360 mg/1 | Capsule, Extended releaseOral | 68382-599 | 68382-0599-0168382-0599-0568382-0599-06+2 more | — |
| Diflunisal | Diflunisal 500 mg/1 | TabletOral | 68382-530 | 68382-0530-0168382-0530-0568382-0530-06+4 more | — |
| Oseltamivir Phosphate | Oseltamivir phosphate 6 mg/mL | For suspensionOral | 70710-1165 | 70710-1165-06 | — |
| Doxazosin | Doxazosin mesylate 1 mg/1 | TabletOral | 68382-783 | 68382-0783-0168382-0783-0668382-0783-10+1 more | — |
| Doxazosin | Doxazosin mesylate 2 mg/1 | TabletOral | 68382-784 | 68382-0784-0168382-0784-0668382-0784-10+1 more | — |
| Doxazosin | Doxazosin mesylate 4 mg/1 | TabletOral | 68382-785 | 68382-0785-0168382-0785-0668382-0785-10+1 more | — |
| Doxazosin | Doxazosin mesylate 8 mg/1 | TabletOral | 68382-786 | 68382-0786-0168382-0786-0668382-0786-10+1 more | — |
| oxybutynin | Oxybutynin chloride 5 mg/1 | Tablet, Film coated, Extended releaseOral | 68382-255 | 68382-0255-0168382-0255-0568382-0255-06+3 more | — |
| oxybutynin | Oxybutynin chloride 10 mg/1 | Tablet, Film coated, Extended releaseOral | 68382-256 | 68382-0256-0168382-0256-0568382-0256-06+3 more | — |
| oxybutynin | Oxybutynin chloride 15 mg/1 | Tablet, Film coated, Extended releaseOral | 68382-257 | 68382-0257-0168382-0257-0568382-0257-06+3 more | — |
| Entecavir | Entecavir .5 mg/1 | Tablet, Film coatedOral | 68382-920 | 68382-0920-0168382-0920-0668382-0920-16+1 more | — |
| Entecavir | Entecavir 1 mg/1 | Tablet, Film coatedOral | 68382-921 | 68382-0921-0168382-0921-0668382-0921-16+1 more | — |
| ezetimibe | Ezetimibe 10 mg/1 | TabletOral | 68382-773 | 68382-0773-0168382-0773-0568382-0773-06+3 more | — |
| Nadolol | Nadolol 20 mg/1 | TabletOral | 68382-732 | 68382-0732-0168382-0732-1068382-0732-16+1 more | — |
| Nadolol | Nadolol 40 mg/1 | TabletOral | 68382-733 | 68382-0733-0168382-0733-1068382-0733-16+1 more | — |
| Nadolol | Nadolol 80 mg/1 | TabletOral | 68382-734 | 68382-0734-0168382-0734-1068382-0734-16+1 more | — |
| Cyproheptadine Hydrochloride | Cyproheptadine hydrochloride 4 mg/1 | TabletOral | 70710-1110 | 70710-1110-0070710-1110-01 | — |
| Eletriptan hydrobromide | Eletriptan hydrobromide 20 mg/1 | Tablet, Film coatedOral | 68382-922 | 68382-0922-0668382-0922-1068382-0922-77+1 more | — |
| Eletriptan hydrobromide | Eletriptan hydrobromide 40 mg/1 | Tablet, Film coatedOral | 68382-923 | 68382-0923-0568382-0923-0668382-0923-77+1 more | — |
| clobetasol propionate | Clobetasol propionate .05 g/mL | SprayTopical | 68382-998 | 68382-0998-0168382-0998-02 | — |
| mesalamine | Mesalamine 1.2 g/1 | Tablet, Delayed releaseOral | 68382-711 | 68382-0711-1968382-0711-64 | — |
| atomoxetine | Atomoxetine hydrochloride 40 mg/1 | CapsuleOral | 68382-218 | 68382-0218-0268382-0218-0668382-0218-10+3 more | — |
Zydus Pharmaceuticals USA Inc.: common questions
- What is Zydus Pharmaceuticals USA Inc.'s NDC labeler code?
- 68382, 70710. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Zydus Pharmaceuticals USA Inc.?
- Med-Code's HCPCS directory matches J2778 to these products. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.